FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lutz Gissmann

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Daniele Viarisio; Birgit Aengeneyndt; Karin Müller Decker; Christa Flechtenmacher; Lutz Gissmann; Massimo Tommasino
Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis.
Gordana Halec; Friedrich Kommoss; Franz X Bosch; Gary Clifford; Bolormaa Dondog; Silvia Franceschi; Tarik Gheit; Lutz Gissmann; Markus Schmitt; Enkhtuya Sharkhuu; Massimo Tommasino; Nicolas Wentzensen; Michael Pawlita
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
Andreas M Kaufmann; Lutz Gissmann; Achim Schneider
The worldwide perspective on human papillomavirus and cervical cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lutz Gissmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniele Viarisio; Birgit Aengeneyndt; Karin Müller Decker; Christa Flechtenmacher; Lutz Gissmann; Massimo Tommasino
Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis.
The Journal of general virology 2013;94(Pt 4):749-52.
2013: Gordana Halec; Friedrich Kommoss; Franz X Bosch; Gary Clifford; Bolormaa Dondog; Silvia Franceschi; Tarik Gheit; Lutz Gissmann; Markus Schmitt; Enkhtuya Sharkhuu; Massimo Tommasino; Nicolas Wentzensen; Michael Pawlita
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer.
International journal of cancer. Journal international du cancer 2013;132(1):63-71.
2012: Andreas M Kaufmann; Lutz Gissmann; Achim Schneider
The worldwide perspective on human papillomavirus and cervical cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1400-1.
2012: Karen Nieto; Christiane Stahl-Hennig; Lutz Gissmann; Barbara Leuchs; Martin Müller; Jürgen A Kleinschmidt
Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques.
Human gene therapy 2012;23(7):733-41.
2012: Iris Cornet; Lutz Gissmann; Jérôme Lamartine; Bakary S Sylla; Miranda Thomas; Rosita Accardi; Lawrence Banks; Veronique Bouvard; Maria Saveria Campo; Massimo Tommasino
Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.
Journal of virology 2012;86(4):2366-70.
2012: Karen Nieto; Mirko Ritter; Richard B S Roden; Sebastian Sedlmeier; Peter Sehr; Hanna Seitz; Margit Weghofer; Lutz Gissmann; Markus Hoerer; Balasubramanyam Karanam; Markus Kellner; Uwe Michaelis; Martin Müller; Jürgen A Kleinschmidt
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.
PloS one 2012;7(6):e39741.
2012: Elizabeth D Gersch; Lutz Gissmann; Robert L Garcea
New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention.
Antiviral therapy 2012;17(3):425-34.
2011: Markus Schmitt; Tim Waterboer; Christine Clavel; Véronique Dalstein; Lutz Gissmann; Michael Pawlita
The HPV16 transcriptome in cervical lesions of different grades.
Molecular and cellular probes 2011;25(5-6):260-5.
2011: Daniele Viarisio; Birgit Aengeneyndt; Christa Flechtenmacher; Tarik Gheit; Lutz Gissmann; Hermann-Josef Gröne; Ulrich Kloz; Annette Kopp-Schneider; Karin Mueller-Decker; Massimo Tommasino
E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.
PLoS pathogens 2011;7(7):e1002125.
2011: Rosita Accardi; Mariafrancesca Scalise; Tarik Gheit; Ishraq Hussain; Jiping Yue; Christine Carreira; Agnese Collino; Cesare Indiveri; Lutz Gissmann; Bakary S Sylla; Massimo Tommasino
IkappaB kinase beta promotes cell survival by antagonizing p53 functions through DeltaNp73alpha phosphorylation and stabilization.
Molecular and cellular biology 2011;31(11):2210-26.
2011: Sonja Textor; Rosita Accardi; Tereza Havlova; Ishraq Hussain; Bakary S Sylla; Lutz Gissmann; Adelheid Cerwenka
NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction.
International journal of cancer. Journal international du cancer 2011;128(5):1104-13.
2010: Tilo Senger; Lysann Schädlich; Sonja Textor; Corinna Klein; Kristina M Michael; Christopher B Buck; Lutz Gissmann
Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.
Vaccine 2010;28(6):1583-93.
2010: Karen Nieto; Lutz Gissmann; Lysann Schädlich
Human papillomavirus-specific immune therapy: failure and hope.
Antiviral therapy 2010;15(7):951-7.
2010: Markus Schmitt; Véronique Dalstein; Tim Waterboer; Christine Clavel; Lutz Gissmann; Michael Pawlita
Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns.
Cancer research 2010;70(1):249-56.
2009: Tilo Senger; Maria R Becker; Lysann Schädlich; Tim Waterboer; Lutz Gissmann
Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.
Journal of virology 2009;83(24):12692-701.
2009: Mauro Morgenfeld; María Eugenia Segretin; Sonia Wirth; Ezequiel Lentz; Alicia Zelada; Alejandro Mentaberry; Lutz Gissmann; Fernando Bravo-Almonacid
Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast.
Molecular biotechnology 2009;43(3):243-9.
2009: Lutz Gissmann; Karen Nieto
The therapeutic vaccine: is it feasible?
Archives of medical research 2009;40(6):493-8.
2009: Lutz Gissmann
HPV vaccines: preclinical development.
Archives of medical research 2009;40(6):466-70.
2009: Lutz Gissmann; Alejandro García-Carrancá
Preface.
Archives of medical research 2009;40(6):427.
2009: Lysann Schädlich; Tilo Senger; Britta Gerlach; Norbert Mücke; Corinna Klein; Ignacio G Bravo; Martin Müller; Lutz Gissmann
Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
Journal of virology 2009;83(15):7690-705.
2009: Peter Ohlschläger; Michael Quetting; Gerardo Alvarez; Matthias Dürst; Lutz Gissmann; Andreas M Kaufmann
Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants.
International journal of cancer. Journal international du cancer 2009;125(1):189-98.
2009: Tilo Senger; Lysann Schädlich; Lutz Gissmann; Martin Müller
Enhanced papillomavirus-like particle production in insect cells.
Virology 2009;388(2):344-53.
2009: Christiane Stahl-Hennig; Martin Eisenblätter; Edith Jasny; Tamara Rzehak; Klara Tenner-Racz; Christine Trumpfheller; Andres M Salazar; Klaus Uberla; Karen Nieto; Jürgen Kleinschmidt; Reiner Schulte; Lutz Gissmann; Martin Müller; Anna Sacher; Paul Racz; Ralph M Steinman; Mariagrazia Uguccioni; Ralf Ignatius
Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques.
PLoS pathogens 2009;5(4):e1000373.
2009: Michael Pawlita; Lutz Gissmann
[Recurrent respiratory papillomatosis: indication for HPV vaccination?].
Deutsche medizinische Wochenschrift (1946) 2009;134 Suppl 2():S100-2.
2009: Ivonne Rubio; Angelo Bolchi; Nadia Moretto; Elena Canali; Lutz Gissmann; Massimo Tommasino; Martin Müller; Simone Ottonello
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin.
Vaccine 2009;27(13):1949-56.
2009: Lysann Schädlich; Tilo Senger; Carsten J Kirschning; Martin Müller; Lutz Gissmann
Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
Vaccine 2009;27(10):1511-22.
2009: Karen Nieto; Andrea Kern; Barbara Leuchs; Lutz Gissmann; Martin Müller; Jürgen A Kleinschmidt
Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.
Antiviral therapy 2009;14(8):1125-37.
2008: Sonja Textor; Matthias Dürst; Lars Jansen; Rosita Accardi; Massimo Tommasino; Marcus J Trunk; Angel Porgador; Carsten Watzl; Lutz Gissmann; Adelheid Cerwenka
Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer.
International journal of cancer. Journal international du cancer 2008;123(10):2343-53.
2008: Margaret Stanley; Lutz Gissmann; Denise Nardelli-Haefliger
Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines.
Vaccine 2008;26 Suppl 10():K62-7.
2008: Wen Dong; C Arpin; Rosita Accardi; Lutz Gissmann; Bakary S Sylla; jacqueline marvel; Massimo Tommasino
Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints.
Oncogene 2008;27(20):2923-8.
2008: Kerstin Leykauf; Kirsten Kabsch; Nikolaus Gassler; Lutz Gissmann; Angel Alonso; Johannes Schenkel
Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern.
Transgenic research 2008;17(1):1-8.
2008: Kerstin Dell; Corinna Klein; Lutz Gissmann
Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
Antiviral therapy 2008;13(4):495-509.
2008: Stephanie Mattil-Fritz; Doreen Scharner; Konrad Piuko; Nadja Thönes; Lutz Gissmann; Hermann Müller; Martin Müller
Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles.
The Journal of general virology 2008;89(Pt 1):138-47.
2007: Andreas M Kaufmann; John D Nieland; Ingrid Jochmus; Siegfried Baur; Klaus Friese; Joseph Gabelsberger; Friederike Gieseking; Lutz Gissmann; Birgit Glasschröder; Thomas Grubert; Peter Hillemanns; Reinhard Höpfl; Hans Ikenberg; Jörg Schwarz; Matthias Karrasch; Anette Knoll; Volkmar Küppers; Martin Lechmann; Ralph J Lelle; Harald Meissner; Rainer T Müller; Michael Pawlita; Karl Ulrich Petry; Henryk Pilch; Elke Walek; Achim Schneider
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).
International journal of cancer. Journal international du cancer 2007;121(12):2794-800.
2007: Maja Gasparić; Ivonne Rubio; Nadja Thönes; Lutz Gissmann; Martin Müller
Prophylactic DNA immunization against multiple papillomavirus types.
Vaccine 2007;25(23):4540-53.
2007: Martin Müller; Lutz Gissmann
[Prophylactic and therapeutic HPV immunization].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2007;58(6):483-4, 486-8.
2007: Lutz Gissmann; Martin Müller
Development of prophylactic HPV vaccines.
Collegium antropologicum 2007;31 Suppl 2():113-5.
2007: Gopeshwar Narayan; Veronique Bourdon; Seeta Chaganti; Hugo Arias-Pulido; Subhadra V Nandula; Pulivarthi H Rao; Lutz Gissmann; Matthias Dürst; Achim Schneider; Bhavana Pothuri; Mahesh Mansukhani; Katia Basso; Raju S K Chaganti; Vundavalli Murty
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
Genes, chromosomes & cancer 2007;46(4):373-84.
2007: Uzma A Hasan; Elizabeth Bates; Fumihiko Takeshita; Alexandra Biliato; Rosita Accardi; Veronique Bouvard; Mariam Mansour; Isabelle Vincent; Lutz Gissmann; Thomas Iftner; Mario Sideri; Frank Stubenrauch; Massimo Tommasino
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(5):3186-97.
2007: Lot de Witte; Younes Zoughlami; Birgit Aengeneyndt; Guido David; Yvette van Kooyk; Lutz Gissmann; Teunis B H Geijtenbeek
Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
Immunobiology 2007;212(9-10):679-91.
2007: Martin Müller; Lutz Gissmann
A long way: history of the prophylactic papillomavirus vaccine.
Disease markers 2007;23(4):331-6.
2006: Regina Samorski; Lutz Gissmann; Wolfram Osen
Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition.
Immunology letters 2006;107(1):41-9.
2006: Nubia Muñoz; Xavier Castellsagué; Amy Berrington de González; Lutz Gissmann
Chapter 1: HPV in the etiology of human cancer.
Vaccine 2006;24 Suppl 3():S3/1-10.
2006: Peter Ohlschläger; Michaela Pes; Wolfram Osen; Matthias Dürst; Achim Schneider; Lutz Gissmann; Andreas M Kaufmann
An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
Vaccine 2006;24(15):2880-93.
2006: Dirk Kuck; Christoph Leder; Andrea Kern; Martin Müller; Konrad Piuko; Lutz Gissmann; Jürgen A Kleinschmidt
Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
Vaccine 2006;24(15):2952-65.
2006: Kerstin Dell; Robert Koesters; Michael Linnebacher; Corinna Klein; Lutz Gissmann
Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levels.
Vaccine 2006;24(13):2238-47.
2006: Dirk Kuck; Tobias Lau; Barbara Leuchs; Andrea Kern; Martin Müller; Lutz Gissmann; Jürgen A Kleinschmidt
Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1.
Journal of virology 2006;80(6):2621-30.
2006: Rosita Accardi; Wen Dong; Anouk Smet; Rutao Cui; Agnès Hautefeuille; Anne-Sophie Gabet; Bakary S Sylla; Lutz Gissmann; Pierre Hainaut; Massimo Tommasino
Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.
EMBO reports 2006;7(3):334-40.
2006: Markus Schmitt; Ignacio G Bravo; Peter J F Snijders; Lutz Gissmann; Michael Pawlita; Tim Waterboer
Bead-based multiplex genotyping of human papillomaviruses.
Journal of clinical microbiology 2006;44(2):504-12.
2006: Kerstin Dell; Robert Koesters; Lutz Gissmann
Transcutaneous immunization in mice: induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumors.
International journal of cancer. Journal international du cancer 2006;118(2):364-72.
2005: Wen Dong; Ulrich Kloz; Rosita Accardi; Sandra Caldeira; Wei-Min Tong; Zhao-Qi Wang; Lars Jansen; Matthias Dürst; Bakary S Sylla; Lutz Gissmann; Massimo Tommasino
Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.
Journal of virology 2005;79(23):14899-908.
2005: Thorsten Steinberg; Peter Ohlschläger; Peter Sehr; Wolfram Osen; Lutz Gissmann
Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice.
Vaccine 2005;23(9):1149-57.
2004: Robert L Garcea; Lutz Gissmann
Virus-like particles as vaccines and vessels for the delivery of small molecules.
Current opinion in biotechnology 2004;15(6):513-7.
2004: Nina Mossadegh; Lutz Gissmann; Martin Müller; Hanswalter Zentgraf; Angel Alonso; Pascal Tomakidi
Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells.
Virology 2004;326(1):57-66.
2004: Eva-Jasmin Freyschmidt; Angel Alonso; Gunther Hartmann; Lutz Gissmann
Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol.
Antiviral therapy 2004;9(4):479-89.
2004: Klaus Braun; Volker Ehemann; Waldemar Waldeck; Rüdiger Pipkorn; Heike Corban-Wilhelm; Jürgen W Jenne; Lutz Gissmann; Jürgen Debus
HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs).
Cancer letters 2004;209(1):37-49.
2004: Gopeshwar Narayan; Hugo Arias-Pulido; Subhadra V Nandula; Katia Basso; Dorcas D Sugirtharaj; Hernan Vargas; Mahesh Mansukhani; Jeannine A Villella; Larissa Meyer; Achim Schneider; Lutz Gissmann; Matthias Dürst; Bhavana Pothuri; Vundavalli Murty
Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.
Cancer research 2004;64(9):2994-7.
2003: Gopeshwar Narayan; Hugo Arias Pulido; Sanjay Koul; Xin-Yan Lu; Charles P Harris; Y Albert Yeh; Hernan Vargas; Hector Posso; Mary Beth Terry; Lutz Gissmann; Achim Schneider; Mahesh Mansukhani; Pulivarthi H Rao; Vundavalli Murty
Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression.
Oncogene 2003;22(22):3489-99.
2003: Peter Ohlschläger; Wolfram Osen; Kerstin Dell; Stefan Faath; Robert L Garcea; Ingrid Jochmus; Martin Müller; Michael Pawlita; Klaus Schäfer; Peter Sehr; Caroline Staib; Gerd Sutter; Lutz Gissmann
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
Journal of virology 2003;77(8):4635-45.
2002: Nico Michel; Wolfram Osen; Lutz Gissmann; Schumacher Ton; Hanswalter Zentgraf; Martin Müller
Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.
Virology 2002;294(1):47-59.
2002: Nico Michel; Peter Ohlschläger; Wolfram Osen; Eva-Jasmin Freyschmidt; Heidrun Guthöhrlein; Andreas M Kaufmann; Martin Müller; Lutz Gissmann
T cell response to human papillomavirus 16 E7 in mice: comparison of Cr release assay, intracellular IFN-gamma production, ELISPOT and tetramer staining.
Intervirology 2002;45(4-6):290-9.
2001: Ingeborg Zehbe; R Tachezy; Joannis Mytilineos; Gianfranco Voglino; I Mikyskova; Hajo Delius; Antonella Marongiu; Lutz Gissmann; Erik Wilander; Massimo Tommasino
Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.
International journal of cancer. Journal international du cancer 2001;94(5):711-6.
2001: Wolfram Osen; T Peiler; Peter Ohlschläger; Sandra Caldeira; Stefan Faath; Nico Michel; Martin Müller; Massimo Tommasino; Ingrid Jochmus; Lutz Gissmann
A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.
Vaccine 2001;19(30):4276-86.
2001: Andreas M Kaufmann; John D Nieland; Manuela Schinz; Marion Nonn; Joseph Gabelsberger; H Meissner; R T Müller; Ingrid Jochmus; Lutz Gissmann; Achim Schneider; Matthias Dürst
HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination.
International journal of cancer. Journal international du cancer 2001;92(2):285-93.
2001: Lutz Gissmann; Wolfram Osen; Martin Müller; Ingrid Jochmus
Therapeutic vaccines for human papillomaviruses.
Intervirology 2001;44(2-3):167-75.
2000: Andreas M Kaufmann; Lutz Gissmann; P Simms; Carola Schreckenberger; Liang Qiao
Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells.
Immunobiology 2000;202(4):339-52.
2000: Wolfram Osen; Ingrid Jochmus; Martin Müller; Lutz Gissmann
Immunization against human papillomavirus infection and associated neoplasia.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;19(1-2):75-8.
2000: Carola Schreckenberger; Periannan Sethupathi; Amornrat Kanjanahaluethai; Martin Müller; J Zhou; Lutz Gissmann; Liang Qiao
Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization.
Vaccine 2000;19(2-3):227-33.
2000: J L Rossi; Lutz Gissmann; K Jansen; M Müller
Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae.
Human gene therapy 2000;11(8):1165-76.
2000: Diana Contreras; P H Krammer; Ronald K Potkul; Ping Bu; J L Rossi; Andreas M Kaufmann; Lutz Gissmann; Liang Qiao
Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(1):67-74.
1999: Ingrid Jochmus; K Schäfer; Stefan Faath; Martin Müller; Lutz Gissmann
Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine.
Archives of medical research 1999;30(4):269-74.
1999: K Schäfer; Martin Müller; Stefan Faath; A Henn; Wolfram Osen; Hanswalter Zentgraf; Axel Benner; Lutz Gissmann; Ingrid Jochmus
Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection.
International journal of cancer. Journal international du cancer 1999;81(6):881-8.
1999: Johannes Schenkel; H Gaissert; E E Protopapa; Hans Weiher; Lutz Gissmann; A Alonso
The human papillomavirus type 11 upstream regulatory region triggers hair-follicle-specific gene expression in transgenic mice.
The Journal of investigative dermatology 1999;112(6):893-8.
1999: F Venturini; J Braspenning; M Homann; Lutz Gissmann; Georg Sczakiel
Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells.
Nucleic acids research 1999;27(7):1585-92.
1999: A Borchers; J Braspenning; J Meijer; Wolfram Osen; Lutz Gissmann; Ingrid Jochmus
E7-specific cytotoxic T cell tolerance in HPV-transgenic mice.
Archives of virology 1999;144(8):1539-56.
1998: Christian M Walz; T R Anisi; Jörg R Schlehofer; Lutz Gissmann; A Schneider; Martin Müller
Detection of infectious adeno-associated virus particles in human cervical biopsies.
Virology 1998;247(1):97-105.
1998: J Paintsil; Martin Müller; M Picken; Lutz Gissmann; J Zhou
Calcium is required in reassembly of bovine papillomavirus in vitro.
The Journal of general virology 1998;79 ( Pt 5)():1133-41.
1998: J Braspenning; W Meschede; Antonio Marchini; Martin Müller; Lutz Gissmann; Massimo Tommasino
Secretion of heterologous proteins from Schizosaccharomyces pombe using the homologous leader sequence of pho1+ acid phosphatase.
Biochemical and biophysical research communications 1998;245(1):166-71.
1998: J Braspenning; Antonio Marchini; V Albarani; L Levy; F Ciccolini; C Cremonesi; R Ralston; Lutz Gissmann; Massimo Tommasino
The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Oncogene 1998;16(8):1085-9.
1998: E Auvinen; Sakari Hietanen; Lutz Gissmann; Angel Alonso
Human papillomavirus type 33 DNA and E6-E7 transcripts in late passages of the UT-DEC-1 vaginal keratinocyte cell line.
Molecular and cellular probes 1998;12(1):59-62.
1998: S Sethi; Martin Müller; Achim Schneider; Maria Blettner; E Smith; L Turek; Jürgen Wahrendorf; Lutz Gissmann; J Chang-Claude
Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women.
American journal of obstetrics and gynecology 1998;178(2):360-4.
1998: W Meschede; Klaus Zumbach; J Braspenning; Martin Scheffner; L Benitez-Bribiesca; J Luande; Lutz Gissmann; Michael Pawlita
Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
Journal of clinical microbiology 1998;36(2):475-80.
1997: Andreas M Kaufmann; Lutz Gissmann; Carola Schreckenberger; Liang Qiao
Cervical carcinoma cells transfected with the CD80 gene elicit a primary cytotoxic T lymphocyte response specific for HPV 16 E7 antigens.
Cancer gene therapy 1997;4(6):377-82.
1997: D Michelin; Lutz Gissmann; D Street; Ronald K Potkul; Susan G Fisher; Andreas M Kaufmann; Liang Qiao; Carola Schreckenberger
Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice.
Gynecologic oncology 1997;66(2):202-8.
1997: Martin Müller; J Zhou; T D Reed; C Rittmüller; A Burger; Joseph Gabelsberger; J Braspenning; Lutz Gissmann
Chimeric papillomavirus-like particles.
Virology 1997;234(1):93-111.
1997: J Braspenning; R Manetti; Klaus Zumbach; W Meschede; Lutz Gissmann; Massimo Tommasino
A general purification protocol for E7 proteins from "high- and low-risk" human papillomavirus types expressed in the yeast Schizosaccharomyces pombe.
Protein expression and purification 1997;10(2):192-201.
1997: Ingrid Jochmus; Wolfram Osen; Annette Altmann; G Buck; B Hofmann; Achim Schneider; Lutz Gissmann; Hans-Georg Rammensee
Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
The Journal of general virology 1997;78 ( Pt 7)():1689-95.
1997: D Street; Andreas M Kaufmann; Andrew T M Vaughan; Susan G Fisher; M Hunter; Carola Schreckenberger; Ronald K Potkul; Lutz Gissmann; Liang Qiao
Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells.
Gynecologic oncology 1997;65(2):265-72.
1997: W J Liu; Lutz Gissmann; X Y Sun; Amornrat Kanjanahaluethai; Martin Müller; J Doorbar; J Zhou
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions.
Virology 1997;227(2):474-83.
1997: K Mund; C Han; R Daum; S Helfrich; Martin Müller; Susan G Fisher; J T Schiller; Lutz Gissmann
Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.
Intervirology 1997;40(4):232-7.
1996: Ingo Nindl; Lutz Gissmann; Susan G Fisher; L B Bribiesca; Jaime Berumen; M Müller
The E7 protein of human papillomavirus (HPV) type 16 expressed by recombinant vaccinia virus can be used for detection of antibodies in sera from cervical cancer patients.
Journal of virological methods 1996;62(1):81-5.
1996: Lutz Gissmann
Immunologic responses to human papillomavirus infection.
Obstetrics and gynecology clinics of North America 1996;23(3):625-39.
1996: J Paintsil; M Müller; M Picken; Lutz Gissmann; J Zhou
Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation.
Virology 1996;223(1):238-44.
1996: C Eisemann; Susan G Fisher; G Gross; M Müller; Lutz Gissmann
Antibodies to human papillomavirus type 11 virus-like particles in sera of patients with genital warts and in control groups.
The Journal of general virology 1996;77 ( Pt 8)():1799-803.
1996: H Stöppler; T Kirchhoff; Jürgen Kartenbeck; Lutz Gissmann; Angel Alonso
Influence of human papillomavirus type 16 gene expression on in vitro differentiation of the human teratocarcinoma cell line 2102Ep.
Molecular carcinogenesis 1996;16(2):109-14.
1996: Andreas M Kaufmann; Lutz Gissmann; D Street; Carola Schreckenberger; M Hunter; Liang Qiao
Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro.
Cellular immunology 1996;169(2):246-51.
1996: Susan G Fisher; L Benitez-Bribiesca; Ingo Nindl; E Stockfleth; Martin Müller; H Wolf; F Perez-Garcia; J Guzman-Gaona; F Gutierrez-Delgado; W Irvin; Lutz Gissmann
The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
Gynecologic oncology 1996;61(1):73-8.
1996: A Hoos; C D'Incan; Lutz Gissmann; Annette Altmann; Frank Momburg; Ingo Nindl; Wolfram Osen; B H Schönning; Ingrid Jochmus
Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture.
Archives of virology 1996;141(3-4):449-58.
1995: J Zhou; Lutz Gissmann; H Zentgraf; H Müller; M Picken; M Müller
Early phase in the infection of cultured cells with papillomavirus virions.
Virology 1995;214(1):167-76.
1995: X Y Sun; Ian H Frazer; M Müller; Lutz Gissmann; J Zhou
Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein.
Virology 1995;213(2):321-7.
1995: M Müller; Lutz Gissmann; R J Cristiano; X Y Sun; Ian H Frazer; A B Jenson; A Alonso; H Zentgraf; J Zhou
Papillomavirus capsid binding and uptake by cells from different tissues and species.
Journal of virology 1995;69(2):948-54.
1994: P Auewarakul; Lutz Gissmann; A Cid-Arregui
Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors.
Molecular and cellular biology 1994;14(12):8250-8.
1993: A Cid; P Auewarakul; A Garcia-Carranca; R Ovseiovich; H Gaissert; Lutz Gissmann
Cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region in transgenic mice and its modulation by tetradecanoyl phorbol acetate and glucocorticoids.
Journal of virology 1993;67(11):6742-52.
1993: Lutz Gissmann; Ingrid Jochmus; Ingo Nindl; M Müller
Immune response to genital papillomavirus infections in women. Prospects for the development of a vaccine against cervical cancer.
Annals of the New York Academy of Sciences 1993;690():80-5.
1993: Ingrid Jochmus; M Dürst; R Reid; Annette Altmann; K E Bijward; Lutz Gissmann; A Bennett Jenson
Major histocompatibility complex and human papillomavirus type 16 E7 expression in high-grade vulvar lesions.
Human pathology 1993;24(5):519-24.
1992: Ingrid Jochmus; J N Bouwes Bavinck; Lutz Gissmann
Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.
Molecular and cellular probes 1992;6(4):319-25.
1992: V Vormwald-Dogan; B Fischer; H Bludau; U K Freese; Lutz Gissmann; D Glitz; E Schwartz; Matthias Dürst
Sense and antisense transcripts of human papillomavirus type 16 in cervical cancers.
The Journal of general virology 1992;73 ( Pt 7)():1833-8.
1992: D Eschle; Matthias Dürst; Jan ter Meulen; J Luande; H C Eberhardt; M Pawlita; Lutz Gissmann
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16.
The Journal of general virology 1992;73 ( Pt 7)():1829-32.
1992: M Müller; Raphael P Viscidi; Y Sun; E Guerrero; PETER HILL; F Shah; Franz X Bosch; N Muñoz; Lutz Gissmann; Keerti V Shah
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
Virology 1992;187(2):508-14.
1992: Annette Altmann; I Jochmus-Kudielka; R Frank; H Gausepohl; U Moebius; Lutz Gissmann; Stefan C Meuer
Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):326-33.
1992: T Kahn; H Friesl; N G Copeland; D J Gilbert; N A Jenkins; Lutz Gissmann; J Kramer; Harald zur Hausen
Molecular cloning, analysis, and chromosomal localization of a mouse genomic sequence related to the human papillomavirus type 18 E5 region.
Molecular carcinogenesis 1992;6(2):88-99.
1991: B Roggenbuck; Peter Mose Larsen; Stephen Fey; D Bartsch; Lutz Gissmann; E Schwarz
Human papillomavirus type 18 E6*, E6, and E7 protein synthesis in cell-free translation systems and comparison of E6 and E7 in vitro translation products to proteins immunoprecipitated from human epithelial cells.
Journal of virology 1991;65(9):5068-72.
1990: M Müller; H Gausepohl; G de Martynoff; R Frank; R Brasseur; Lutz Gissmann
Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1.
The Journal of general virology 1990;71 ( Pt 11)():2709-17.
1990: Magnus von Knebel Doeberitz; Lutz Gissmann; Harald zur Hausen
Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression.
Cancer research 1990;50(12):3730-6.
1989: I Jochmus-Kudielka; A Schneider; R Braun; R Kimmig; U Koldovsky; K E Schneweis; K Seedorf; Lutz Gissmann
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.
Journal of the National Cancer Institute 1989;81(22):1698-704.
1989: D Gallahan; M Müller; A Schneider; Hajo Delius; T Kahn; Ethel-Michele de Villiers; Lutz Gissmann
Human papillomavirus type 53.
Journal of virology 1989;63(11):4911-2.
1989: M Müller; G Kelly; M Fiedler; Lutz Gissmann
Human papillomavirus type 48.
Journal of virology 1989;63(11):4907-8.
1989: J Schmitt; Jörg R Schlehofer; K Mergener; Lutz Gissmann; Harald zur Hausen
Amplification of bovine papillomavirus DNA by N-methyl-N'-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with herpes simplex virus.
Virology 1989;172(1):73-81.
1989: Lutz Gissmann; I Jochmus-Kudielka
Immune response to papillomavirus infections.
Current problems in dermatology 1989;18():162-7.
1988: B Forbes; Lutz Gissmann; M Pawlita
Detection of individual virus-infected cells by filter in situ hybridization.
Molecular and cellular probes 1988;2(3):245-53.
1988: Magnus von Knebel Doeberitz; T Oltersdorf; E Schwarz; Lutz Gissmann
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.
Cancer research 1988;48(13):3780-6.
1987: T Oltersdorf; K Seedorf; W Röwekamp; Lutz Gissmann
Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies.
The Journal of general virology 1987;68 ( Pt 11)():2933-8.
1987: Matthias Dürst; R T Dzarlieva-Petrusevska; Petra Boukamp; Norbert E Fusenig; Lutz Gissmann
Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA.
Oncogene 1987;1(3):251-6.
1987: Magnus von Knebel Doeberitz; Lutz Gissmann
Analysis of the biological role of human papilloma virus (HPV)-encoded transcripts in cervical carcinoma cells by antisense RNA.
Haematology and blood transfusion 1987;31():377-9.